Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varda Rotter

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|June 23, 2009
The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic geneVered Daniel-Carmi, Efrat Makovitzki-Avraham, Eliran-Moshe Reuven, et al.
The Journal of Experimental Medicine|August 11, 2010
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cellsRachel Sarig, Noa Rivlin, Ran Brosh, et al.
Molecular Systems Biology|May 27, 2006
The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformationYuval Tabach, Michael Milyavsky, Igor Shats, et al.
BMC Cancer|March 7, 2014
The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cellsTal Leibovich-Rivkin, Yulia Liubomirski, Tsipi Meshel, et al.
Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Oncogene|August 29, 2003
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsAmir Zalcenstein, Perry Stambolsky, Lilach Weisz, et al.
Molecular and Cellular Biology|September 19, 2007
Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type IIEyal Kalo, Yosef Buganim, Keren E Shapira, et al.
Carcinogenesis|October 10, 2008
Modulated expression of WFDC1 during carcinogenesis and cellular senescenceShalom Madar, Ran Brosh, Yosef Buganim, et al.
Plos Pathogens|May 5, 2018
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in miceEtai Rotem, Omri Faingold, Meital Charni, et al.
Cell Death and Differentiation|October 15, 2016
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein responseRoi Isaac, Ido Goldstein, Noa Furth, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|June 23, 2009
The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic geneVered Daniel-Carmi, Efrat Makovitzki-Avraham, Eliran-Moshe Reuven, et al.
The Journal of Experimental Medicine|August 11, 2010
Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cellsRachel Sarig, Noa Rivlin, Ran Brosh, et al.
Molecular Systems Biology|May 27, 2006
The promoters of human cell cycle genes integrate signals from two tumor suppressive pathways during cellular transformationYuval Tabach, Michael Milyavsky, Igor Shats, et al.
BMC Cancer|March 7, 2014
The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cellsTal Leibovich-Rivkin, Yulia Liubomirski, Tsipi Meshel, et al.
Omics : a Journal of Integrative Biology|February 22, 2011
ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promotersStefania Dell'Orso, Giulia Fontemaggi, Perry Stambolsky, et al.
Oncogene|August 29, 2003
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutantsAmir Zalcenstein, Perry Stambolsky, Lilach Weisz, et al.
Molecular and Cellular Biology|September 19, 2007
Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type IIEyal Kalo, Yosef Buganim, Keren E Shapira, et al.
Carcinogenesis|October 10, 2008
Modulated expression of WFDC1 during carcinogenesis and cellular senescenceShalom Madar, Ran Brosh, Yosef Buganim, et al.
Plos Pathogens|May 5, 2018
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in miceEtai Rotem, Omri Faingold, Meital Charni, et al.
Cell Death and Differentiation|October 15, 2016
TM7SF3, a novel p53-regulated homeostatic factor, attenuates cellular stress and the subsequent induction of the unfolded protein responseRoi Isaac, Ido Goldstein, Noa Furth, et al.
Pageof 13